📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Functional and Economic Impact of INOCA and Influence of Coronary Microvascular Dysfunction (2021)

First Author: Schumann C

Attributed to: MICA: A Developmental Trial of Personalised Medicine for Repurposing Zibotentan, a Selective Endothelin A Receptor Blocker, in Microvascular Angina. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jcmg.2021.01.041

PubMed Identifier: 33865784

Publication URI: http://europepmc.org/abstract/MED/33865784

Type: Journal Article/Review

Parent Publication: JACC: Cardiovascular Imaging

Issue: 7